Editorial: Closing in on the Role of Thymic Stromal Lymphopoietin Inhibition as a Therapeutic Entry Point for Systemic Sclerosis
Publication date
2016-11-01
Authors
Affandi, Alsya J.
van Roon, Joel A.G.
Editors
Advisors
Supervisors
Document Type
Editorial
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Immunology and Allergy, Rheumatology, Immunology
Citation
Affandi, A J & van Roon, J A G 2016, 'Editorial : Closing in on the Role of Thymic Stromal Lymphopoietin Inhibition as a Therapeutic Entry Point for Systemic Sclerosis', Arthritis and Rheumatology, vol. 68, no. 11, pp. 2571-2574. https://doi.org/10.1002/art.39815